| 标题 |
Cost-effectiveness of blinatumomab versus salvage chemotherapy in relapsed or refractory Philadelphia-chromosome-negative B-precursor acute lymphoblastic leukemia from a US payer perspective |
| 网址 | |
| DOI | |
| 其它 |
期刊:Journal of Medical Economics 作者:Thomas E. Delea; Jordan Amdahl; Diana Boyko; May Hagiwara; Zachary F. Zimmerman; et al 出版日期:2017-06-20 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)